重组抗荧光素单抗(4-4-20 (enhanced)),小鼠IgG2c Kappa | Syd Labs PA007702.m2c
Syd Labs体内实验级重组抗荧光素(Anti-Fluorescein / Anti-FITC)单克隆抗体,克隆号 4-4-20(enhanced,亲和力增强版),恒定区为小鼠 IgG2c Kappa(Mouse IgG2c Kappa),由哺乳动物细胞重组表达,序列明确、无杂交瘤遗传漂变风险、无腹水内源抗体污染,特异性识别荧光素(Fluorescein/FITC/FAM)核心呫吨环结构,对游离荧光素及FITC-蛋白/核酸/葡聚糖偶联物具有亚纳摩尔级高亲和力(K_d ~ 10⁻¹⁰ M)。小鼠 IgG2c 是C57BL/6、NOD、SJL、129等Igh-1b等位基因型品系(即全球使用最广泛的基因工程小鼠背景品系)天然表达的Th1型强效应IgG亚类,功能上等效于BALB/c等Igh-1a品系的IgG2a,核心特性:①强ADCC活性——高亲和力结合所有小鼠激活性FcγR(FcγRI/CD64、FcγRIII/CD16、FcγRIV),其中对FcγRIV亲和力略高于IgG2a,ADCC活性与IgG2a相当甚至更强,为各亚类顶级水平;②强CDC活性——高亲和力结合小鼠C1q,高效激活补体经典途径,补体依赖细胞毒活性强;③Protein G强结合、Protein A弱结合——与IgG2a强结合Protein A不同,IgG2c仅弱结合或不结合Protein A,纯化必须用Protein G亲和层析;④Igh-1b品系体内完全同源、无同种异型反应——C57BL/6、NOD、SJL、129等品系自身天然表达IgG2c、不表达IgG2a,注射IgG2c不会像IgG2a那样被识别为同种异型抗原引发抗同种异型抗体(anti-allotype antibody),是这些品系体内长期/重复给药实验的唯一安全、有效的强效应亚型;⑤Th1型应答标志——IFN-γ驱动,在C57BL/6品系的抗病毒、抗肿瘤、胞内菌感染免疫应答中产生,是该品系Th1免疫的标志性亚类。荧光素(Fluorescein)又称 FITC(异硫氰酸荧光素)、FAM(6-羧基荧光素)、Resorcinolphthalein、Uranine(荧光素钠)、C.I. 45350,是呫吨类绿色荧光染料(Ex≈494 nm/Em≈521 nm)。小鼠IgG2c版本特别适用于:①C57BL/6等Igh-1b品系小鼠体内靶细胞杀伤/耗竭实验(核心不可替代用途)——全球70%以上的基因敲除/转基因/人源化小鼠均为C57BL/6背景,使用IgG2c可避免IgG2a引发的同种异型抗体反应和快速清除;②C57BL/6来源细胞的ADCC/CDC功能实验;③C57BL/6品系Th1型免疫应答研究;④流式/WB/ELISA/IHC检测(需用抗小鼠IgG2c特异性二抗或泛抗鼠IgG二抗);⑤C57BL/6小鼠IgG2c同型对照。注意:BALB/c等Igh-1a品系不表达IgG2c,BALB/c体内实验请用IgG2a版本,BALB/c注射IgG2c同样会引发同种异型反应。本品经Protein G亲和纯化,还原性SDS-PAGE及HPLC检测纯度>95%,0.2 μM过滤于1×PBS溶液,适用于C57BL/6等品系体内细胞杀伤、ADCC/CDC功能实验、流式、WB、ELISA、IHC/IF及侧向流检测。
产品参数
| 货号 | PA007702.m2c |
|---|---|
| 产品名称 | 重组抗荧光素单抗(4-4-20 (enhanced)),小鼠IgG2c Kappa | Syd Labs PA007702.m2c |
| 英文名 | Recombinant Anti-Fluorescein Monoclonal Antibody (Clone: 4-4-20 (enhanced)), Mouse IgG2c Kappa |
| 供货商名称 | Syd Labs, Inc. |
| 品牌名 | Syd Labs |
| 别称 | Fluorescein、FITC(Fluorescein isothiocyanate / 异硫氰酸荧光素 / 荧光素异硫氰酸酯)、FAM(6-Carboxyfluorescein / 6-羧基荧光素)、Fluorescein isomer I、Resorcinolphthalein、Uranine(荧光素钠)、C.I. 45350、D&C Yellow No.7 |
| 克隆号 | 4-4-20 (enhanced) |
| 同种型 | 小鼠IgG2c Kappa |
| 特异性 | 特异性结合荧光素(Fluorescein/FITC/FAM)核心呫吨环结构,对游离荧光素及 FITC-蛋白/抗体/葡聚糖/核酸偶联物均有高亲和力 |
| 抗体形式 | 0.2 μM 过滤的 1× PBS 溶液 |
| 纯度 | 还原性条件下 SDS-PAGE 及 HPLC 检测>95% |
| 运输 | 采用冰袋运输;收到后请立即按下方推荐温度保存 |
| 稳定性与存储 | 使用手动除霜冰箱,避免反复冻融;自收货之日起12个月,按供货状态于−20 ℃至−70 ℃保存;自收货之日起1个月,按供货状态于2 ℃至8 ℃保存 |
| 产品咨询 | Syd Labs在国内只通过代理商销售其产品,不做直销。终端用户咨询价格请联系Syd Labs中国代理商。 关于Syd Labs产品如果有任何技术或其它问题,欢迎随时联系Syd Labs国内市场推广合作伙伴:武汉多找找科技有限公司,企业微信:duozhaozhao2024 联系电话:18162581039(龙经理) |
| 应用详情 | Western Blot(抗小鼠IgG2c-HRP或泛抗鼠IgG-HRP二抗检测)、Flow Cytometry(抗IgG2c-荧光二抗)、ELISA;可用于C57BL/6、NOD、SJL、129等Igh-1b品系(含绝大多数基因敲除/转基因/人源化小鼠)体内靶细胞特异性耗竭/杀伤实验、ADCC/CDC功能实验、Th1型抗病毒/抗肿瘤免疫研究、IHC/IF、侧向流免疫层析试纸(LFT/LFD)及C57BL/6小鼠IgG2c同型对照 |
文献
PA007702.m2c: Syd Labs 重组抗荧光素单克隆抗体(克隆号4-4-20 (enhanced)) ,小鼠IgG2c Kappa(Recombinant Anti-Fluorescein Monoclonal Antibody (Clone: 4-4-20 (enhanced)), Mouse IgG2c Kappa)
重组抗荧光素单抗(4-4-20 (enhanced))背景知识:
我们的重组抗荧光素抗体(克隆号 4-4-20 增强型)为序列明确、哺乳动物细胞表达的抗 FITC 单克隆抗体,可特异性识别结合在蛋白、多肽、核酸或固相基质上的荧光素母核结构。该重组抗荧光素半抗原抗体稳定性高、性能可靠,是识别荧光素标记靶标、在各类常规体外免疫检测中放大信号的关键二步检测试剂,可彻底规避杂交瘤细胞株遗传漂移带来的风险。
相较于传统生物素 – 链霉亲和素体系,荧光素 / 抗荧光素检测体系具备突出优势:生物素广泛存在于多种哺乳动物组织及细胞裂解液中,因此基于生物素的检测往往背景偏高、易出现假阳性;而生物样本中天然不含荧光素,使用这款重组抗 FITC 单克隆抗体能够完全消除内源背景干扰。因此,该抗荧光素半抗原抗体非常适合用于复杂样本的体外诊断、ELISA 以及高通量筛选平台,可获得低背景、高准确度的实验数据。
我们可针对 4-4-20 增强型骨架提供全套抗体定制改造与规模化生产服务,面向诊断试剂盒研发企业及科研实验室。可提供的定制类型包括:
亚型转换与 Fc 改造:多种重链 / 轻链亚型以及改造型 Fc 变体(如效应沉默 LALAPG 突变体);
亲和标签:可重组添加 Avi 标签、His 标签或 DYKDDDDK(FLAG)标签,适配特定实验取向;
标记偶联:生物素化版本,也可直接偶联多种荧光基团、染料以及酶(辣根过氧化物酶 HRP、碱性磷酸酶 AP)。
重组抗荧光素单抗(4-4-20 (enhanced))部分参考文献:
1. CRISPR/Cas12a and fork-shaped probe enhance LAMP-LFT integration for equipment-free detection of Listeria monocytogenes.
Safenkova IV, et al.
Food Res Int. 2026 Apr;230:118592. PMID: 41794473 DOI: 10.1016/j.foodres.2026.118592
“An isothermal amplification assay integrated with lateral flow test (LFT) was developed for equipment-free detection of Listeria monocytogenes. In both LAMP-LFT and LAMP-CRISPR/Cas12a-LFT formats, fluorescein- and biotin-labeled amplicons were detected using a common conjugate of gold nanoparticles and anti-fluorescein (anti-FAM) antibodies, with a cleaved fork-shaped multi-fluorescein probe enabling visual readout on strips coated with anti-FAM capture antibody. The optimized assay achieved a single-cell detection limit (0.2 cells/reaction in buffer, 1 cell/reaction in spiked milk) within 80 min.”
2.A Versatile Cytochemical Labeling Technique as a Forensic Decision-Support Tool for In Situ Detection of Cell-Derived Markers in Invisible Biological Traces.
Bastat M, et al.
Anal Chem. 2025 Oct;97(41):22497–22507. PMID: 41057037 DOI: 10.1021/acs.analchem.5c02284
“A dual chromogenic and fluorescent in situ cytochemistry tool was developed to highlight invisible touch-DNA traces (e.g., fingermark corneocytes) on crime-scene surfaces. Chromogenic labeling of mannose residues and keratin 10 allowed visualization of as few as 100 shed cells, while a combination of FITC-conjugated primary probes and an HRP-conjugated anti-FITC antibody enabled simultaneous chromogenic and fluorescent detection across light and opaque substrates (ceramic, metal), supporting on-field sampling decisions prior to DNA extraction.”
3.Development of Reverse Transcriptase Recombinase Polymerase Amplification Combined with Lateral Flow Dipstick for Rapid Detection of Tilapia Lake Virus (TiLV): Pilot Study.
Srivorakul S, et al.
Vet Sci. 2025 Sep;12(9):845. PMID: 41012770 DOI: 10.3390/vetsci12090845
“A reverse-transcriptase recombinase polymerase amplification assay combined with a lateral flow dipstick (RT-RPA-LFD) was developed for point-of-care detection of Tilapia Lake Virus. The dipstick was prepared with immobilized anti-FITC and anti-biotin capture antibodies compatible with TiLV-specific primers tagged with FITC and biotin. Reverse transcription and RPA amplification were completed at 39 °C within 20 min, and products were visualized as a positive band on the LFD, achieving a 3.19 copies/µL limit of detection—a 100-fold improvement over RT-PCR-LFD.”
4.Identification, sorting and profiling of functional killer cells via the capture of fluorescent target-cell lysate.
Luah YH, et al.
Nat Biomed Eng. 2024 Mar;8(3):248–262. PMID: 37652987 DOI: 10.1038/s41551-023-01089-z
“PAINTKiller, a flow-cytometry-compatible assay for identifying and sorting functional cytotoxic effector cells in co-cultures, relies on capturing the intracellular carboxyfluorescein succinimidyl ester released from lysed target cells onto the surface of the killing lymphocyte. Capture was achieved using a bispecific complex consisting of an anti-fluorescein isothiocyanate antibody linked to an antibody against the pan-leucocyte receptor CD45, which ‘painted’ the natural killer cell surface with fluorescent lysate and enabled FACS sorting followed by single-cell RNA-seq profiling of killer-cell subpopulations.”
5.Fluorescein-switching-based lateral flow assay for the detection of microRNAs.
Ryu JY, et al.
Org Biomol Chem. 2024 Oct;22(40):8182–8188. PMID: 39291769 DOI: 10.1039/d4ob01311e
“A fluorescein-switching lateral flow assay was developed for naked-eye detection of microRNA biomarkers (miR-6090 and miR-141 for prostate cancer). Reduced fluorescein on the probe only weakly binds gold-nanoparticle-conjugated anti-fluorescein antibodies; in the presence of target microRNA, riboflavin tetraacetate photo-oxidizes the probe back to native fluorescein, which strongly binds the antibodies on the strip to produce a visible line. Sodium borohydride was introduced to minimize background, enabling fmol-level microRNA detection with minimal false positives for point-of-care cancer diagnostics.”




